Latest total liabilities for BLTE: $15M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Belite Bio (BLTE) currently reports a total liabilities of $15M as of March 2026. That compares with $6.1M in the prior-year period — up 152.5% year over year. Use the charts on this page to explore Belite Bio's total liabilities history and peer comparisons.
Belite Bio's total liabilities increased from $6.1M to $15M — a 152.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Belite Bio reported $15M in total liabilities as of March 2026. That compares with $6.1M in the prior-year period — up 152.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Belite Bio, and consider following BLTE for alerts when major investors trade the stock.